Why Hospital Stocks Crashed Today: Supreme Court Questions 10X Medicine Mark-Up | Parimal Ade

Indian hospital stocks went into a tailspin today, with giants like Apollo, Max, and Fortis seeing massive intraday declines. Why the panic? The Supreme Court of India has dropped a bombshell over the "carnage" of medicine pricing, specifically calling out a staggering 10x markup on cancer drugs. In this video, we break down: The Supreme Court's "broad daylight dacoity" remark regarding hospital medicine pricing. The proposed 16% margin cap that has investors trembling. Why mandatory in-house pharmacy rules are now under the legal microscope. The dual-threat impact on hospital profitability and business models. Why Fortis Healthcare is facing additional forensic audit pressure. Is this the end of the hospital rally, or a temporary regulatory scare? We analyze the potential long-term impact before the next critical hearing on October 12, 2026. Research Based Ready-made Model Portfolios: https://investyadnya.in/model-portfolios Yadnya Books and eBooks now available: On Amazon - https://amzn.to/47x0RS4 On Flipkart - https://fktr.in/y3OZ3GF On our website - https://shop.investyadnya.in Find us on Social Media and stay connected: Whatsapp Channel - https://whatsapp.com/channel/0029Va6N... Blog - https://blog.investyadnya.in Telegram - http://t.me/InvestYadnya Facebook Page -   / investyadnya   Twitter -   / investyadnya   LEGAL DISCLAIMER: Use of this information is at the user's own risk. The Company and its directors, associates and employees will not be liable for any loss or liability incurred to the user due to investments made or decisions taken based on the information provided herein. The investment discussed or views expressed herein may not be suitable for all investors. The users should rely on their own research and analysis and should consult their investment advisors to determine the merit, risks and suitability of recommendation. Past performance is not a guarantee for future performance or future results. Information herein is believed to be reliable, although its accuracy and completeness cannot be guaranteed. The images used may be copyright of the company or third party. As a condition to using the services, the user agrees to the terms of use of the website and the services. DISCLOSURES UNDER SEBI (RESEARCH ANALYST) REGULATIONS, 2014: Yadnya Academy Pvt. Ltd. (InvestYadnya) is registered with SEBI under SEBI (Research Analyst) Regulations, 2014 with registration no. INH000008349. Disclosure with regard to ownership and material conflicts of interest 1. Neither Research Analyst nor the entity nor his associates or relatives have any financial interest in the subject Company; 2. Neither Research Analyst nor the entity nor its associates or relatives have actual / beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report or date of public appearance; 3. Neither Research Analyst nor the entity nor its associates or his relatives have any other material conflict of interest at the time of publication of the research report or at the time of public appearance. Disclosure with regard to receipt of Compensation 1. The Research Entity and its associates have not received compensation from the subject company in the past twelve months. 2. The subject company is not or was not a client during the twelve months preceding the date of recommendation.